I don't see ALT ever becoming 'big' in their own right. I think they may be able to prove the product works i.e. delivers good results for patients. This is the potential for a gain on their sp. It is not their first try at developing something and they should have learnt from previous experience. If they can prove the product they should then look for someone to buy it. ... 12-Jul-2014.
